chrisvoncsefalvay/vaers-outcomes huggingface dataset:
lesion on ankle; muscle and joint cap pain; muscle and joint cap pain; feeling ringing in her ears; ankle swelling; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A 59 year-old female patient received bnt162b2 (BNT162B2), administration date 21Jul2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: JOINT INJURY (non-serious), outcome "unknown", described as "lesion on ankle"; TINNITUS (non-serious) with onset Aug2021, outcome "unknown", described as "feeling ringing in her ears"; JOINT SWELLING (non-serious) with onset Aug2021, outcome "unknown", described as "ankle swelling"; MYALGIA (non-serious), ARTHRALGIA (non-serious) all with onset 02Aug2021, outcome "unknown" and all described as "muscle and joint cap pain". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: The patient reported that the lesion on ankle is on her bone looked like it was from years ago or from when she was born but about a week ago it started bothering her.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A pt stated his left arm was numb after we gave him the COVID imz on 1-21-22. It started 15 days after we gave the shot. He said the numbness comes and goes but happens every day. We saw the image and it did not state which arm the shot was given in but the computer said RIGHT ARM. The pt spoke. He told my technician he thought the system was lying and wanted to see the dr here. We explained there is no md here. The technician told him to go see a doctor. We pulled the hard copy and the right arm was circled. We called the pt again and he will go to another facility to see an md after a week from today. I asked for him to follow up with us please to let us know how he is doing. I apologized to him that he is having problems.
No adverse event; 16 patients were administered pediatric monovalent vaccines instead of bivalent boosters; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR6965B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Dec-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 21-Dec-2022, the patient experienced WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters) outcome was unknown and NO ADVERSE EVENT (No adverse event) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (16 patients were administered pediatric monovalent vaccines instead of bivalent boosters).    Reporter reported that 16 patients were administered pediatric monovalent vaccines instead of bivalent boosters on 21-Dec-2022. Doses were administered by IM injection. No symptoms were reported . 1 patient was 15 years old while were 15 adult patients.  No concomitant medication reported. No treatment medication reported.   This case was linked to MODERNATX, INC.-MOD-2022-692175 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2022-692175:Master case
This spontaneous report was received from a physician via a company representative concerning a 38 year old female patient. The patient's medical history included splenectomy. On 21-JUL-2015, the patient was vaccinated with PNEUMOVAX 23 (lot # K012424, expiration date: June 2016), (dose, route and frequency were not described). The reporter stated that the patient received this vaccine every 5 years. Concomitant medications included tramadol (reported as tramadal). Later, on 22-JUL-2015, the patient experienced soreness and a hard time moving her arm. For treatment, the patient used an ice pack. The patient sought medical attention. No product quality complaint was reported. At the time of this report, the outcome of soreness and the hard time moving her arm events, was recovering. Additional information has been requested.
She saw her dermatologist on 12/18/21, had a tiny tiny crust/scratch on her forehead that was frozen, was not concerned about it.  She got her vaccine, started to get a rash on her forehead where it was frozen and above her eyebrow.  She has one larger area on her forehead, another one above her eyebrow and 3 or more in her scalp region.  It started to get larger and larger and went to the doctor again, was not sure what it was.  She gave her topical cream that did not help, and went back last week, she did a biopsy which showed discoid lupus.  She is going to be referred to a rheumatologist.  She did not have any issues with lupus before the vaccine.     She also has not had any skin conditions prior to this either.     Dermatologist, Seen two of the Doctors at the same location.
Within Minutes of receiving vaccines on 8/22/06 pt with blotches on face. This winter informed MD and ordered per MD to give pt Benadryl. Within minutes blotches diminished. Received call 8/23/06 that pt left deltoid red and swollen. Pt came in to office lt deltoid red, warm and swollen. Pt treated with 1 gm Rocephin. Benadryl and ice. Upon recheck on 8/24/06 pt lt deltoid with decreased redness and no swelling.
No symptoms reported.; inadvertent administration of expired PROQUAD to a patient; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's historical medications, medical history, concurrent conditions and concomitant medications were not reported.      On 08-FEB-2022, the patient was vaccinated an expired dose of with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot number T027114, expiration date 07-FEB-2022, 0.5 milliliter (route of administration not reported) for prophylaxis that was diluted with sterile diluent(MERCK STERILE DILUENT) (expired product administered). No adverse event was reported.
Pt had numbness in hand of immunized arm and could not use. Then developed itchy, redness and swelling at vaccination site.
On 10/23/18, at approximately 12 noon, I received the 2nd dose of the SHINGRIX vaccine from my medical provider. (I previously had the first dose in April 2018 with no problems or symptoms). I felt fine the rest of the day. The very next day I had severe diarrhea, slight nausea, and lots of stomach churning. I spent the day in bed and took 4 IMODIUM doses. I drank lots of water and ate toast, rice, crackers and cheese. I slept a lot. I was ok the next day (10/24/18), and back to normal by 10/25/18. I had no bowel movements at all until 10/26/18, which were slightly constipated. I have also had a very sore left shoulder with slight swelling at the site of the vaccine injection since I received it on 10/23/18. It prevents me from sleeping on my left side at night. I am reporting these symptoms after talking to other women who had a similar experience with this vaccine.
This is a spontaneous report from a contactable pharmacist. A 69-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot number: unknown), via intramuscular route of administration in the left arm on 16Mar2021 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient had a history of allergy to penicillin. The concomitant medication was not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. On 16Mar2021 the patient experienced tingling under both eyes at rest. The patient did not receive any treatment for reported event. The event didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event tingling under both eyes at rest was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.
became dizzy; went to his knees; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (became dizzy) and DIZZINESS POSTURAL (went to his knees) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (became dizzy) and DIZZINESS POSTURAL (went to his knees). At the time of the report, DIZZINESS (became dizzy) and DIZZINESS POSTURAL (went to his knees) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
The patient was brought to the vaccination site in a facility on 12/07/2021 by their mother. The patient was vaccinated with their first dose of pediatric Pfizer at 9:00 A.M., .2ml and 10mcg. The patient was observed then released. On the same day, 12/07/2021 at 3:00 P.M., the patient was brought to the vaccination site in a facility for a second time by their grandfather.  The patient followed the same registration process. They were registered and prior to receiving the vaccine, the vaccinator verified that the patient had not received a prior dose of the vaccine per the local Immunization Registry.  The patient was vaccinated with another dose of pediatric Pfizer, .2ml and 10mcg per shot.
person reported itching on her arms. Person moved to observation area and was there at the same time as another person with n/v. Person then progressed to n/v as well. While EMS assessed the other person they also assessed her. She was hypertensive. Benadryl was given. She also reported only 4 hours of sleep and not having anything to eat before getting vaccine.
Flu like symptoms; Generalized aching; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Generalized aching), PYREXIA (Fever) and CHILLS (Chills) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB for Plaque psoriasis.    No Medical History information was reported.   On 18-Nov-2020, the patient started RISANKIZUMAB (Subcutaneous) at an unspecified dose. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2020, the patient experienced PYREXIA (Fever). In February 2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Generalized aching) and CHILLS (Chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved and PAIN (Generalized aching), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In February 2021, Body temperature: unknown (Inconclusive) Unknown.         Treatment information was not provided.   This case was linked to MOD-2021-073087 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 31-May-2021: Follow-up information received on 31-May-2021 no new information was recorded
14-yo, F, vaccinated with J&J single dose. Minor went home w/ guardian. Onset of s/s were @ 1800 on 10/20, malaise, chest pain, lethargy, back pain, and joint pain. On 10/21 @ 0900 guardian took minor to an UC, where they advised to monitor for worsening s/s and to give minor Benadryl. As of 1600 hours on 10/21, s/s have not worsened, pt is home recovering. I advised to seek medical care if s/s worsen. I provided my contact info. to sister (guardian) for f/u and q/a.
Fever, laryngitis,malaise,rash - information has been received from a registered nurse concerning a 36 year old male, who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation 635921/1181k.  Subsequently, the patient experience a mile rash, fever, general malaisa and laryngitis.  Unspecified medical attention was sought.  The patient recovered from a mile rash, fever, genral malaise and laryngitis.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2016, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2016, the patient was treated by a physician for a blistering vesicular outbreak which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
Case number PHEH2012US021210 is an initial spontaneous report received from a pharmacist on 15 Oct 2012: This case refers to an 18-years-old female patient. She was received only Men C, Y, W-135 liquid conjugate component of MENVEO vaccine (batch number: not reported), intramuscularly without being reconstituted with Men A component on an unspecified date in Aug 2012. No adverse reaction reported following this administration error.
This spontaneous report was received from a consumer on behalf of her husband as a 66 year old male patient with penicillin allergy. On 07-JUL-2014, the patient was vaccinated with ZOSTAVAX 1 single shot (frequency and lot # unspecified (exp. 29-FEB-2014)). Concomitant medication included Teratozon y Alperanal (therapies unspecified). After vaccination, the patient developed shingles on the patient's inner left thigh, leg, front of the chest and neck and was hospitalized for 12 days (unspecified dates). On 26-JUL-2015, the patient developed the second case of shingles on the patient's inner left thigh, leg, front of the chest and neck. On an unspecified date in July 2015, the patient experienced sweating and dehydration and was admitted to the hospital due to a low grade fever (specific date and duration of hospitalization were unknown). At the time of this report, the outcome of second case of shingles on the patient's inner left thigh, leg, front of the chest and neck, sweating, dehydration and low grade fever was reported as recovering. The outcome of the patient's first case of shingles was unknown. Additional information has been requested.
Adacel (Tdap) was given to <11 yo pt 10 y & 10 months.
High fever >102.5 Extreme joint pain Body aches Blotchy skin rash on abdomen, neck, and  face Pregnancy confirmed 4 days after vaccine reaction, implantation would have possible occurred during the time of the vaccine reaction.  Pregnancy was determined to be ectopic - in right fallopian tube.  Concerned the severe vaccine reaction was the reason for improper embryo implantation.
broke out in hives/ bumps; This is a spontaneous report from a contactable consumer (patient). A 32-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0150, Expiration Date: 31Jul2021), via an unspecified route of administration, administered in the left arm on 19Apr2021 (at the age of 32 years old) as dose 1, single for COVID-19 immunisation. The patient has no medical history. The patient's concomitant medications were not reported. On 19Apr2021, the patient broke out in hives and went to the emergency room. He also reported that he took the vaccine on 19Apr2021 and once he went to home he was taking out with bumps, the real bumps and he went to the emergency room. The patient underwent lab tests and procedures which included blood work: unknown results on an unspecified date in Apr2021. The patient was given medications for bumps and the hives which included prednisone 20mg and IC famotidine 20mg (as reported). The patient was improving (recovering) from the event.  No follow-up attempts are possible. No further information is expected
9-24-18 - Patient called - right arm is red/blotchy with yellow/purple area around injection site - arm is sore. 10-3-18 - call her to check - almost back to normal - a bit puffy - can lift arm now.
On 1st capsule nausea & abdominal cramping & diarrhea; discontinued because sensitive to vax & did not want to continue w/pain;
Small, circular, rough, red mark on mid chest. Another mark is beginning - does have a small head on it. Not itchy or painful.
Information has been received from a registered nurse (RN) concerning a 13-month-old male with no medical history of allergies who on 12-JUL-2006, 15-SEP-2006 (Lot #653754/0139F) and 03-NOV-2006 (Lot #655484/1032F) was vaccinated PO with the first, second and third doses, respectively, of Rotateq. There was no concomitant therapy. The RN reported that on 10-JUN-2007, the patient developed fever, vomiting and diarrhea. Unspecified medical attention was sought. On 12-JUN-2007, a rotavirus test was positive. At the time of this report, the patient was noted to be recovering. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/16/2007.  Information has been received from a registered nurse (RN) concerning a 13-month-old male with no medical history or allergy who on 12-JUL-2006 at 3:00PM (Lot #653754/0139F), 15-SEP-2006 at 3:15 PM (Lot #653754/0139F) and 03-NOV-2006 at 4:30 PM (Lot #655484/1032F) was vaccinated PO with the first, second and third doses, respectively, of ROTATEQ.  There was no illness at the time of vaccination.  There was no concomitant therapy.  The RN reported that on 10-JUN-2007, the patient developed fever, vomiting and diarrhea.  Unspecified medical attention was sought.  On 12-JUN-2007, a rotavirus test was positive.  At the time of this report, the patient was noted to be recovering.  There were no adverse events following prior vaccinations of the patient or his siblings.  Follow up informtion indicated that the patient had rotavirus with fever and vomiting despite vaccination with ROTATEQ.  The outcome was recovered.  No additional information is expected.
Patient states had some pain in head which resolved before leaving, also some numbness on left side of face which was still there. Patient also states that left hand was slightly swollen and vision was slightly blurry.  Patient requested a bottle of  water which was given to them.
Site became red, hot, and tender with redness spreading down arm and to arm pit by day 4. Started ABX on 25th and finally got better on 7/28. Pain did not improve until 7/27/2018. No fever. Redness slowly fading each day a little more completely gone on 7/30/2018.
Patient 3/19/1959 started to feel dizzy and nauseated after her Moderna Covid 19 immunization.  Had patient sit for extended observation.  Started feeling better around 10pm.
F/U to VAERS e-report temporary #747382 (submitted 12/16/2021)  Patient has had several additional episodes of vertigo post-initial occurrence on 12/16/2021 that resulted in head laceration. The episodes have become increasingly more frequent and patient has been experiencing a substantial disruption of the ability to conduct daily life activities. Patient has been evaluated by several specialists and recently received an initial diagnosis of vestibular neuritis. Patient is scheduled to undergo a brain MRI, a hearing test and a balance test to rule out other causes. F/U report written at 11:01AM on 01/23/2022, patient?s course of illness continues.
For over a year, my life style has changed dramatically. I have had muscle aches and pains particulary in both arms-also swelling in the lower arms (wrists) and hands especially on rising in the AM. I was a golfer and walker/gardnes/ with muchmobility. I find it hard to do certain arm motions and still have difficulty with side and overhead arm functions. The swelling persists I trace it to the LYMErix vacine as other events seem constant. I sought special treatment i.e. physical therapy and a rheumatoid specialist.
Lymph nodes swollen on left side of neck (right above collarbone) & in front of left armpit.  Started to hurt the middle of yesterday and puffed up more overnight (2nd night after vaccine). General body aches yesterday (day after shot) but not as many today although swelling is a bit worse.  Tender to the touch.
titres drawn recently which were negative for both mealses and mumps; titres drawn recently which were negative for both mealses and mumps; This spontaneous report was received from a registered pharmacist referred to an adult female patient of unknown age. The patient's pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On an unknown date the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II) injection, 1 dosage form, via subcutaneous route for prophylaxis (lot # and expiry date were not reported). It was not sure if the patient had received the vaccine and the patient did not have medical records from childhood to indicate when, if ever she had received the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live(M-M-R II). On 11-NOV-2019, measles, mumps and rubella titers were drawn and was negative for both measles and mumps. Rubella titer result was unknown. There was no treatment given for the events. The outcome of the events was not resolved. The reporter did not provide any causality assessment. Product quality complaint was not involved.
As per employee report:  After my vaccine on 4/14/21 at designated vaccine site, I felt fine for the first 24 hours. At about the 24 hour mark my heart rate increased by about 20 bpm. I also started running a fever and my lymph nodes in my armpit was incredibly swollen. The following day, the fever was gone, but my heart rate was still high and every now and then jumping way up to 130ish bpm. That evening I went to bed and was awoken by my heart beating really fast and I monitored it on my Fitbit.. It raced up to about 170 bpm. At that point we made a trip to the ER.
Migraine low grade fever body aches chills nausea  and extremely tired took Tylenol slept
Second dose administered  fewer than 24 days (Moderna) after the first dose (i.e., administered earlier than the 4-day grace period)
HEALTH CARE WORKER ARMS WAS SWOLLEN , ITCHY, HARD AND PAINFUL AFTER SECOND DOSE OF GETTING PFIZER  COVID-19 VACCINE
Dizziness, numbness of both hands. Placed in supine position for 40 minutes. Apple juice given. BS 92 to 137. BP 142/67 (pulse 69), O2 sat 100%. Repeat BP 150/79 (pulse 69), O2 sat 100%.